Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 -0.04 (-6.48%)
As of: Sep 30, 2026 · 2:25 PM EDT

Outlook Therapeutics (OTLK) Operating Expenses (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) reported Operating Expenses of $10.8 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 35.8% from $16.81 million a year earlier and down 22.9% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Operating Expenses (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Outlook Therapeutics' Operating Expenses came in at $53.36 million, down 27.6% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $67.12 million, down 6.4% from FY2024.

  • Operating Expenses has a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • By fiscal year, Operating Expenses came in at $71.7 million in FY2024 (+35.0%), $53.13 million in FY2023 (-15.8%), $63.07 million in FY2022 (+21.9%) and $51.73 million in FY2021 (+40.4%).
  • The fiscal Q3 2026 figure ranks as the lowest quarterly Operating Expenses since fiscal Q1 2024.
  • Year over year, Operating Expenses gained in three of the last eight quarters, with growth averaging 6.2%.
  • The high point for year-over-year Operating Expenses in five years was fiscal Q2 2024 (growth of 177.0%); the low point was fiscal Q2 2023 (a decline of 63.8%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $14.01 million (Q2 2026), $12.25 million (Q1 2026) and $16.31 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Outlook Therapeutics 86.15 Mn 50.40 Mn -8,265.00 10.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.80 Mn
Mar 31, 2026 14.01 Mn
Dec 31, 2025 12.25 Mn
Sep 30, 2025 16.31 Mn
Jun 30, 2025 16.81 Mn
Mar 31, 2025 12.39 Mn
Dec 31, 2024 21.61 Mn
Sep 30, 2024 22.88 Mn
Jun 30, 2024 19.56 Mn
Mar 31, 2024 18.94 Mn
Dec 31, 2023 10.32 Mn
Sep 30, 2023 12.46 Mn
Jun 30, 2023 18.14 Mn
Mar 31, 2023 6.84 Mn
Dec 31, 2022 15.69 Mn
Sep 30, 2022 13.99 Mn
Jun 30, 2022 17.02 Mn
Mar 31, 2022 18.91 Mn
Dec 31, 2021 13.15 Mn
Sep 30, 2021 13.44 Mn
API Access

Outlook Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEY